Johanna Adami is the director and head of health at VINNOVA, Sweden's innovation agency. She discusses Sweden's national innovation strategy and VINNOVA's role in funding research and innovation. VINNOVA aims to address grand challenges like health, the environment, and an aging population through collaborative projects bringing together researchers, industries, and other stakeholders both within Sweden and internationally. VINNOVA's health programs support personalized medicine, life sciences, and reforming healthcare to be more innovation-focused. The future roadmap involves stronger public-private partnerships and providing evidence of innovation outcomes.

1. Johanna Adami
Professor and Director and Head of Health
Division VINNOVA , Swedish Government
Agency for Innovation System, Sweden
National perspective Sweden

2. Challenge driven innovations for future health – a roadmap for success
Johanna Adami, MD MPH PhD Professor
Director and Head of Health Division

3. Sweden – A small, open economy
•Sweden is sparsely populated. 9,7 million inhabitants…
•…but large: Surface area 450,000 km2.
•Exports: 46 percent of GDP - 30 percent services and 70 percent goods
•Foreign owned enterprises employ more than 630,000 persons. Around 13 percent of total employment.
•Foreign owned enterprises perform around 38 percent of the business R&D in Sweden.

4. Total R&D expenditure in relation to GDP, 2011
Source: OECD, MSTI 2014
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
Norway
Canada
United Kingdom
China
Netherlands
Singapore
Australia
Belgium
France
Estonia
Slovenia
Iceland
USA
Austria
Switzerland (2008)
Germany
Denmark
Taiwan
Japan
Sweden
Finland
Israel
Korea
Percent of GDP
Business enterprise
Higher education
Government sector
Other organisations

5. Sweden ranks high in innovation and competitiveness
Innovation Union Scoreboard 2014
Global Competitiveness Index 2013/2014
Switzerland
Switzerland
Sweden
Singapore
Denmark
Finland
Germany
Germany
Finland
United States
Luxembourg
Sweden
Netherlands
Hong Kong
Belgium
Netherlands
United Kingdom
Japan
Ireland
United Kingdom
Source: Innovation Union Scoreboard 2014 and World Economic Forum, Global Competitiveness Report 2013/14.

6. Bild 6

7. The Challenge ahead
Slide 7
How to stay competetive long term?
•Continued creation of high productive jobs – Attract and retain R&D activities
•Build on existing strengths
•Embrace globalization
•Removing barriers – Innovation policy crucial

8. National Innovation strategy
Bild 8
•2020 time horizon
•Broad definition of innovation
•Focus on societal challenges
•Holistic approach to innovation and innovation support
•Innovation as a driver of national attractiveness and competitiveness

9. VINNOVA – Sweden´s Innovation Agency

10. VINNOVA in brief
•VINNOVA – the Swedish Governmental Agency for Innovation responding to the Ministry of Enterprise
•About 200 people work at VINNOVA’s offices in Stockholm, Brussels and Silicon Valley
•Annual budget of 300 million Euros invested in innovation projects in all sectors in society.

11. Three roles
Funding Research & Innovation
National EU Contact Agency
Expert Agency

12. Funding Research and innovation

13. Implementation!
Strategic Innovation Areas
Implementation!
EU-coordination secretariat
Implementation!
Develop the Knowledge triangle approach at universities
VINNOVA focus

14. 2014-09-26
Bild 14
Key principles of operation
•for increased impacts of research
•broad innovation perspective; goods, services, processes, etc.
•confidence in the actors to define their own development strategies
•we develop and test new forms for investments
•we develop and strengthen beneficial international cooperation

15. Key features of VINNOVA programs
Funding through grants
Main funding mechanism at VINNOVA
Program period of 3-10 years
One or several open ”call-for-proposals”
Project requirements:
•Industry-relevant
•Industry-academy-research institute- public sector partners
•Co-funding, VINNOVA max. 50%
•1-10 years projects
•Level of funding appr. € 0.3 to 10 M per project

16. International programs
Bild 16
North and South America
USA: Road/Vehicle Safety Innovation program
Brazil: Innovation program
Europe
EU FP7, ERAnets, INCOnets, AAL, Artemis, Eniac, EUREKA, COST, Eurostars, TAFTIE, BSR
Nordic region
ICT, e-Gov’t, Transport policy
Asia
India Life sci.y/health, ICT
Japan Multidisciplinary Bio (JST to 2013), Network projects (JSPS)
China ICT (concluded, Material science, Eco-innovation
Other cooperations
South Korea, Canada, Israel: EUREKA/Eurostars
Active government agreement in S&T and/or innovation
Formalized cooperation with budget
Bilateral program
Eureka/Eurostars

17. We are facing a number of grand challenges
Environment
Health
Ageing
population
Globalization

18. To address these challenges
You need to
•Bring world class research together
•Combine skills from many sectors
•Apply known technologies into new applications
•Utilize the best expertise from all over the world
Bild 18
opportunities

19. 2014-09-26
Bild 19
Future
Health
Diagnostics

20. Strategy for Health Innovation
Bild 20
Global re-structuring in lifescience
Global health challenges: lifestyle, demographic changes, etc
Health care challenges; cost vs quality – innovation potential
Weak links between high-quality research and needs-driven innovation
Business meets global health needs
Globally attractive innovation system
Health care - partner in innovation
VISION
CHALLENGES

21. Ongoing programs in health
Bild 21
Test beds
International collaborations
Public procurement
Collaboration
Business, Public sector & Academia
Innovation hubs
Incubators
European collaboration programs
R&D&I Projects

22. Personlized medicine – some results
VINN Cardio – biomarkers for individualized treament for cardiovascular disease
Create Health – individualized cancer treatment
Tailored Leukapheresis for treatment of immune mediated inflammatory diseases
Endemic diseases: To make Sweden one of the world's leading ecosystems for life science focusing on diabetes and other endemic diseases.
2014-09-26
Bild 22

23. ECOSYSTEM for health/lifescience/health care/
INDUSTRY
PATIENT
HEALTH CARE DELIVERY
Payers/fiscal intermediaries
Medical technology
Pharma- ceuticals
Diagnostics
Public
Private
Professional groups
AUTHORITIES
Regulating
RESEARCH/
EDUCATION
Regulatory
Industry- organisations
SME
Large companiess

24. Roadmap for the future
Reform health care –public sector should be a partner in innovation
 Stimulate valuedriven innovation for all
Provide evidence for the outcomes
Work closely with regulatory agencies
Promote Incentives such as reimbursement models, public procurement etc.
Support databases/registries
Public Private Partnership
Promote active partnership with relevant stakeholders
2014-09-26
Bild 24

25. Collaboration is the basis for all VINNOVA funding
2014-09-26
Bild 25
X
Sectors
Research fields
Technologies
Types of Actors
Nations

26. Connect
Catalyse
Stimulate

27. Bild 27

28. Thank you!
Johanna.adami@vinnova.se
Bld 28